FDA initiatives to support dose optimization in oncology drug development: the less may be the better
- Author:
Hanlim MOON
1
Author Information
- Publication Type:Commentary
- From:Translational and Clinical Pharmacology 2022;30(2):71-74
- CountryRepublic of Korea
- Language:English
